According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...

As biologically inspired nanocarriers, virus-like particles combine safety with functional adaptability. Their capacity for modular design supports innovation in immunotherapy, targeted drug delivery, and advanced diagnostic technologies. The global virus-like particles market is entering a phase of sustained expansion, with projected growth from US$ 6.25 billion in 2025 to US$ 12.15 billion by...

As biologically inspired nanocarriers, virus-like particles combine safety with functional adaptability. Their capacity for modular design supports innovation in immunotherapy, targeted drug delivery, and advanced diagnostic technologies. The global virus-like particles market is entering a phase of sustained expansion, with projected growth from US$ 6.25 billion in 2025 to US$ 12.15 billion by...